Effect of delayed castration on the growth rate, behaviour and serum insulin-like growth factor-1 concentration of beef cattle on tropical pasture

2002 ◽  
Vol 75 (1) ◽  
pp. 41-47
Author(s):  
C. Gazzola ◽  
M. R. Jeffery ◽  
D. H. White ◽  
R. A. Hill ◽  
D. J. Reid

AbstractMale beef calves in northern Australia are generally castrated under 6 months of age as an aid to management of animal behaviour and for the purpose of producing sufficiently fat carcasses at slaughter. It is also common for beef producers to administer hormone growth promotants, such as oestradiol, to increase the growth rates of steers at pasture. This experiment tested the hypothesis that delaying castration by 9 months would produce an increase in growth rate for the period while the cattle are retained as bulls without compromising management of animal behaviour. Bulls of three genotypes were castrated at 7 months or 16 months of age and half were treated with oestradiol after castration. Body weight (BW) and serum insulin-like growth factor-1 concentrations (IGF-1) were measured and behaviour was observed before and after the 16 month castration. At both 7 and 16 months of age, surgical castration of bulls caused no animal welfare problems. BW gain was affected by genotype with Bos taurus types having a lower BW gain than Bos indicus and F1-cross cattle. IGF-1 was similarly affected by genotype. Oestradiol treatment increased growth of the steers (early castrates) during the 9 months between castration times compared with non-implanted steers and bulls. Oestradiol implanted steers had similar BW gain from the late castration to slaughter, regardless of age at castration, which was greater than non-implanted early castrates which, in turn, was greater than the late castrates. Similar differences were observed for IGF-1 concentrations. Behaviour was not affected by genotype, oestradiol treatment or age of castration but this may have been an artefact of the design where all treatment groups were grazed together. Although delayed castration resulted in no behavioural or management problems, it did not produce a commercially useful increase in growth rate.

2015 ◽  
Vol 83 (4) ◽  
pp. 474-477 ◽  
Author(s):  
Roman Dąbrowski ◽  
Marek Szczubiał ◽  
Krzysztof Kostro ◽  
Władysław Wawron ◽  
Jose J. Ceron ◽  
...  

2000 ◽  
Vol 85 (4) ◽  
pp. 1433-1439
Author(s):  
Anthony J. Cleare ◽  
Samantha S. Sookdeo ◽  
Jennifer Jones ◽  
Veronica O’Keane ◽  
John P. Miell

GH deficiency states and chronic fatigue syndrome (CFS) share several characteristics, and preliminary studies have revealed aspects of GH dysfunction in CFS. This study assessed indexes of GH function in 37 medication-free CFS patients without comorbid psychiatric illness and 37 matched healthy controls. We also assessed GH function before and after treatment with low dose hydrocortisone, which has been shown recently to reduce fatigue in CFS. We measured basal levels of serum insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-2 and IGFBP-3 together with 24-h urinary GH excretion. We also performed 2 dynamic tests of GH function: a 100-μg GHRH test and an insulin stress test using 0.15 U/kg BW insulin. There were no differences between patients and controls in basal levels of IGF/IGFBP or in urinary GH excretion. GH responses to both the GHRH test and the insulin stress test were no different in patients and controls. CFS patients did have a marginally reduced suppression of IGFBP-1 during the insulin stress test. Hydrocortisone treatment had no significant effect on any of these parameters. There is no evidence of GH deficiency in CFS. At the doses used, hydrocortisone treatment appears to have little impact on GH function.


1993 ◽  
Vol 73 (3) ◽  
pp. 509-516 ◽  
Author(s):  
A. G. Van Kessel ◽  
R. S. Korchinski ◽  
B. Laarveld

The colostral transfer of maternal humoral immunity against somatostatin (SRIF) was examined as a mechanism of improving growth performance of the lamb. Lambs were the offspring of 15 ewes actively immunized against an SRIF-ovalbumin conjugate (SI; 14 male, 7 female) and of 13 ewes actively immunized against ovalbumin (C; 10 male, 5 female). At 5 d of age, lambs were removed from the ewes and received a 50:50 mixture of whole cow's milk and milk replacer ad libitum. At 46 d of age lambs were weaned and provided with an 18% crude protein pelleted grower ration ad libitum. Lamb weight was recorded and blood samples were obtained at regular intervals from 5 to 46 d of age and at 102 d of age. From 5 to 46 d of age, immunization increased growth rate of male (P < 0.001) but not female lambs. Serum thyroxine (T4) was lower (P < 0.001) in male than in female lambs. Serum triiodothyronine (T3) was higher (P < 0.05) in SI male than in C male lambs. SI female lambs initially demonstrated higher serum T3 levels than C female lambs, but this effect reversed after 19 d of age. Serum insulin-like growth factor I (IGF-I) levels were higher (P = 0.08) in SI than in C lambs without significant influence of sex. From 46 to 102 d of age, somatostatin immunization increased growth rate of male (P = 0.08) but not female lambs. Serum levels of T4, T3 and IGF-I at 102 d of age were not affected by immunization. Passive immunization against SRIF through colostral transfer of immunity may improve growth rate of the lamb via an influence on thyroid hormone metabolism. Key words: Sheep, somatostatin, immunoneutralization. growth, thyroid, IGF-I


Sign in / Sign up

Export Citation Format

Share Document